iAnthus Capital HoldingsFRA:2IA -50.00% Current Ratio is 0.70 as of Mar. 2026, which is 4% above its 10-year median of 0.67. The stock has 4 warning signs investors should review. Among 995 Drug Manufacturers companies, iAnthus Capital Holdings ranks worse than 91.06% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. iAnthus Capital Holdings's current ratio for the quarter that ended in Mar. 2026 was 0.70.
iAnthus Capital Holdings has a current ratio of 0.70. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If iAnthus Capital Holdings has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for iAnthus Capital Holdings's Current Ratio or its related term are showing as below:
FRA:2IA'
s Current Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.67 Max: 12.54
Current: 0.7
During the past 11 years, iAnthus Capital Holdings's highest Current Ratio was 12.54. The lowest was 0.19. And the median was 0.67.
FRA:2IA's Current Ratio is ranked worse than 91.06% of 995
companies
in the Drug Manufacturers industry
Industry Median: 2
vs FRA:2IA: 0.70
iAnthus Capital Holdings (FRA:2IA) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
iAnthus Capital Holdings Current Ratio Related Terms
iAnthus Capital Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iAnthus Capital Holdings Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where iAnthus Capital Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iAnthus Capital Holdings (FRA:2IA) has a Current Ratio of 0.70 as of Mar. 2026. This is near median its historical median of 0.67. Over the past decade, iAnthus Capital Holdings' Current Ratio has ranged from 0.19 to 12.54. According to the industry distribution chart, iAnthus Capital Holdings ranks #906 out of 995 companies in the Drug Manufacturers industry, placing it in the top 91.1%.
Is iAnthus Capital Holdings' Current Ratio too high?
iAnthus Capital Holdings' current Current Ratio of 0.70 is near median its 10-year median of 0.67. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 12.54. The Drug Manufacturers industry median Current Ratio is 2.00. iAnthus Capital Holdings' value of 0.70 is 65% below this industry median. Based on the distribution chart, iAnthus Capital Holdings ranks #906 out of 995 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does iAnthus Capital Holdings' Current Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, iAnthus Capital Holdings ranks #906 out of 995 companies for Current Ratio. This places iAnthus Capital Holdings in the lower half of its industry. The industry median Current Ratio is 2.00. iAnthus Capital Holdings' value of 0.70 is 65% below this benchmark. Historically, iAnthus Capital Holdings' own Current Ratio has ranged from 0.19 to 12.54 over the past decade. While the company's 10-year median is 0.67 vs. the industry median of 2.00, iAnthus Capital Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 995 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iAnthus Capital Holdings's current Current Ratio of 0.70 is 65% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iAnthus Capital Holdings's current Current Ratio is 0.70, which is near median its own 10-year median of 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current Current Ratio of 0.70. The current Current Ratio is 0.70, which is near median its 10-year median of 0.67 and 65% below the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current Current Ratio is 0.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2IA has been successfully added to your 